Metabolic side effects of psychotropic drugs
( Psychiatry and Clinical Psychopharmacology 2014; 24: S51-S51)
by Fernandez- Miranda et al.
by Akdeniz et al.
by Cakiroglu and Soylu.
( Psychiatry and Clinical Psychopharmacology 2014; 24: S51-S51)
( Psychiatry and Clinical Psychopharmacology 2014; 24: S45-S45)
( Psychiatry and Clinical Psychopharmacology 2014; 24: S44-S44)
( Psychiatry and Clinical Psychopharmacology 2014; 24: S42-S42)
Nazan Aydın, Mesut Cetin, Erhan Kurt, Haluk Savas, Cengizhan Açıkel, Selim Kılıç, Cengiz Basoglu, Hakan Türkçapar
( Psychiatry and Clinical Psychopharmacology 2013; 23: 390-402) DOI: 10.5455/bcp.20131230121254
( Psychiatry and Clinical Psychopharmacology 2011; 21: 161-173) DOI: 10.5455/bcp.20110706032759
Mehmet Demet, Filiz Deniz, Emine Şimşek, E.Oryal Taşkın, Artuner Deveci
( Psychiatry and Clinical Psychopharmacology 2003; 13: 43-49)
( Psychiatry and Clinical Psychopharmacology 2002; 12: 31-36)
Mesut Çetin, Samet Köse, Servet Ebrinç, Aslıhan Kıstak
( Psychiatry and Clinical Psychopharmacology 2002; 12: 159-164)
( Psychiatry and Clinical Psychopharmacology 1999; 9: 208-212)
( Psychiatry and Clinical Psychopharmacology 1998; 8: 1-7)
Nesrin Karamustafalıoğlu, H.Erdem Karaman, Nihat Alpay
( Psychiatry and Clinical Psychopharmacology 1997; 7: 11-16)
( Psychiatry and Clinical Psychopharmacology 1992; 2: 54-57)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S59-S292)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S103-S104)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S77-S77)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S55-S55)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S49-S50)
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)